Can TRT Cause Testicular Pain? (TRT Q&As)
Timeline
A 38-year-old man on TRT reports developing testicular pain after initially feeling well. Dr. O’Connor explains that testicular atrophy can occur with androgen use and HCG may help maintain testicular fullness, but persistent pain warrants evaluation by a urologist and ultrasound to rule out problems such as torsion, cysts, or cancer.
A 44-year-old man with testosterone around 260, low HDL, and elevated LDL asks whether he should address his cholesterol first. Dr. O’Connor emphasizes assessing the complete cardiovascular picture, including blood pressure, A1C, family history, and potentially a coronary calcium score, before committing to long-term TRT.
A member reports that glute injections have become swollen and painful for days afterward while using a 23-gauge, 1.5-inch needle. Dr. O’Connor discusses using smaller needles, smaller injection volumes, and alternative sites such as the ventrogluteal area, deltoids, or appropriate areas of the thigh.
Dr. O’Connor says the decision should not be based on testosterone numbers alone and wants to know the member’s symptoms, including sexual function. He emphasizes that beginning TRT at age 42 can become a long-term commitment and should be considered carefully before treatment is started.
Dr. O’Connor identifies the deposits as xanthelasma and explains their association with lipid abnormalities. He discusses evaluating the underlying cardiovascular and metabolic picture with a lipid panel, advanced markers such as ApoB and Lp(a), A1C, thyroid and metabolic testing, family history, and potentially a coronary calcium score.
A 58-year-old man reports feeling poorly after being prescribed enclomiphene, an aromatase inhibitor, and 200 mg of testosterone, and asks about starting with a much lower testosterone dose instead. Dr. O’Connor discusses a lower-dose, individualized approach, monitoring estrogen without automatically using an AI, and evaluating cardiovascular health as treatment is adjusted.
Video Summary
This mailbag discussion focuses on questions where individuals report mixed or conflicting symptoms during testosterone therapy. It explains that improvements and setbacks can coexist due to sleep, stress, nutrition, timing, and unrelated health variables. Symptom complexity is framed as common rather than contradictory.
A central portion discusses why single symptoms should not be evaluated in isolation. The episode emphasizes looking for patterns over time instead of reacting to individual days. Contextual assessment is highlighted to avoid misattribution.
The closing segment reinforces the importance of patience and longitudinal observation. Ongoing monitoring, proportional interpretation, and expectation alignment are emphasized. Hormone therapy is positioned as requiring trend-based evaluation rather than moment-to-moment judgment.
Drug Callouts
Condition Callouts
Key Takeaways
- Mixed symptom patterns are common during therapy.
- Daily fluctuations reflect multiple influences.
- Isolated days can mislead interpretation.
- Trend-based assessment improves clarity.
- Patience supports better long-term decisions.